EL
ENDRA Life Sciences Inc.
SEC filingBiotechnology · Ann Arbor, MI
Amount raised$14.4Msold at filing
Total offering$14.4M
Investors in the raise6count reported to the SEC
FiledOct 24, 2025first sale Oct 10, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Michael ThorntonExecutive Officer
Richard JacrouxExecutive Officer
Louis J. BaseneseDirector
Anthony J. DiGiandomenicoDirector
Michael J. HarshDirector
Alexander TokmanExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.